Guidelines on the management of drug‐induced immune and secondary autoimmune, haemolytic anaemia

Abstract

The objective of this guideline is to provide healthcare professionals with guidance on the management of patients with secondary autoimmune haemolytic anaemia (AIHA). The guidance may not be appropriate to every patient and in all cases, individual patient circumstances may dictate an alternative approach.